All questions are shown as received by the Trust.
Q1. How many patients have been treated (for any condition) in the last 4 months with:
• Benralizumab
• Dupilumab
• Omalizumab
• Reslizumab
• Mepolizumab
• Tezepelumab
Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:
• Age 6 – 11
• Age 12 – 17
• Age 18 and above
Q3. How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with:
• Dupilumab
• Omalizumab